Ropidoxuridine in Treating Patients With Advanced Gastrointestinal Cancer Undergoing Radiation Therapy
ACTIVE_NOT_RECRUITING
Status
Conditions
- Advanced Bile Duct Carcinoma
- Stage II Esophageal Cancer AJCC v7
- Stage II Pancreatic Cancer AJCC v6 and v7
- Stage IIA Esophageal Cancer AJCC v7
- Stage IIA Pancreatic Cancer AJCC v6 and v7
- Stage IIB Esophageal Cancer AJCC v7
- Stage IIB Pancreatic Cancer AJCC v6 and v7
- Stage III Colon Cancer AJCC v7
- Stage III Esophageal Cancer AJCC v7
- Stage III Gastric Cancer AJCC v7
- Stage III Liver Cancer
- Stage III Pancreatic Cancer AJCC v6 and v7
- Stage III Rectal Cancer AJCC v7
- Stage III Small Intestinal Cancer AJCC v7
- Stage IIIA Colon Cancer AJCC v7
- Stage IIIA Esophageal Cancer AJCC v7
- Stage IIIA Gastric Cancer AJCC v7
- Stage IIIA Rectal Cancer AJCC v7
- Stage IIIA Small Intestinal Cancer AJCC v7
- Stage IIIB Colon Cancer AJCC v7
- Stage IIIB Esophageal Cancer AJCC v7
- Stage IIIB Gastric Cancer AJCC v7
- Stage IIIB Rectal Cancer AJCC v7
- Stage IIIB Small Intestinal Cancer AJCC v7
- Stage IIIC Colon Cancer AJCC v7
- Stage IIIC Esophageal Cancer AJCC v7
- Stage IIIC Gastric Cancer AJCC v7
- Stage IIIC Rectal Cancer AJCC v7
- Stage IV Colon Cancer AJCC v7
- Stage IV Esophageal Cancer AJCC v7
- Stage IV Gastric Cancer AJCC v7
- Stage IV Liver Cancer
- Stage IV Pancreatic Cancer AJCC v6 and v7
- Stage IV Rectal Cancer AJCC v7
- Stage IV Small Intestinal Cancer AJCC v7
- Stage IVA Colon Cancer AJCC v7
- Stage IVA Liver Cancer
- Stage IVA Rectal Cancer AJCC v7
- Stage IVB Colon Cancer AJCC v7
- Stage IVB Liver Cancer
- Stage IVB Rectal Cancer AJCC v7
Interventions
- RADIATION: Intensity-Modulated Radiation Therapy
- OTHER: Laboratory Biomarker Analysis
- OTHER: Pharmacological Study
- DRUG: Ropidoxuridine
Sponsor
National Cancer Institute (NCI)